Skip to main contentLink to External Link Policy

Because of a lapse in Government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding Government operating status and resumption of normal operations can be found at OPM.gov.

Evaluating the Therapeutic Potential of Cannabinoids: How to conduct research within the current regulatory framework

Date: December 8, 2018 - 08:00 a.m. ET to 5:15 p.m. ET

Event Description

The National Center for Complementary and Integrative Health (NCCIH), at the National Institutes of Health (NIH), sponsored a workshop on December 8, 2018 to discuss the processes and issues related to conducting cannabinoid research. “Evaluating the therapeutic potential of cannabinoids: How to conduct research within the current regulatory framework” brought together researchers, government officials, and industry representatives to discuss the processes and issues related to conducting cannabinoid research.

The meeting was from 8:00 a.m. to 5:15 p.m. (ET) and was available via livestream. 

The goals of this meeting were to:

  • Gain an understanding of how to navigate this regulatory space
  • Discuss future research opportunities
  • Foster collaborations

The focus of this workshop was on the state of the science and working within current regulations. This meeting did NOT discuss challenging or changing current Federal laws, policies or regulations.

For more information, contact Dr. Angela Arensdorf, Science Policy Analyst, Office of Policy, Planning, and Evaluation, National Center for Complementary and Integrative Health, at angela.arensdorf@nih.gov.